Deciphera Pharmaceuticals (STU:D05) Accumulated Depreciation : €0.0 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Deciphera Pharmaceuticals Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Deciphera Pharmaceuticals's quarterly accumulated depreciation increased from Sep. 2023 (€0.0 Mil) to Dec. 2023 (€-11.2 Mil) but then stayed the same from Dec. 2023 (€-11.2 Mil) to Mar. 2024 (€0.0 Mil).

Deciphera Pharmaceuticals's annual accumulated depreciation increased from Dec. 2021 (€-6.3 Mil) to Dec. 2022 (€-9.5 Mil) and increased from Dec. 2022 (€-9.5 Mil) to Dec. 2023 (€-11.2 Mil).

Deciphera Pharmaceuticals Accumulated Depreciation Historical Data

The historical data trend for Deciphera Pharmaceuticals's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Deciphera Pharmaceuticals Accumulated Depreciation Chart

Deciphera Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated Depreciation

Get a 7-Day Free Trial

-1.65

-3.39

-6.32

-9.52

-11.19

Deciphera Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accumulated Depreciation	Get a 7-Day Free Trial															-	-	-	-11.19	-

Deciphera Pharmaceuticals Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Deciphera Pharmaceuticals Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Deciphera Pharmaceuticals's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Deciphera Pharmaceuticals (STU:D05) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Deciphera Pharmaceuticals Inc (STU:D05) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

DCPH:USA

Address

200 Smith Street, Waltham, MA, USA, 02451

Website

https://www.deciphera.com

Deciphera Pharmaceuticals Inc is a biotechnology company, which develops and manufactures kinase-inhibiting drugs for the treatment of cancers and immunological diseases. It holds a diverse pipeline of drug candidates that includes three clinical-stage and two research-stage programs. Its lead drug candidate DCC-2618 is designed to inhibit the full spectrum of mutant or amplified KIT and Pdgfra kinases that drive cancers such as gastrointestinal stromal tumors, advanced systemic mastocytosis, gliomas, and other solid tumors. In addition, it is also developing two other clinical-stage drug candidates, DCC-3014 and Rebastinib. Geographically all the operations function through the region of the United States.

Deciphera Pharmaceuticals (STU:D05) Headlines

No Headlines